Yves Beuzard
Creteil, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors.
Journal: Transfusion
Published: November 18, 2025
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial.
Journal: Nature medicine
Published: December 08, 2020
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
Journal: The New England journal of medicine
Published: April 19, 2018
Gene Therapy in a Patient with Sickle Cell Disease.
Journal: The New England journal of medicine
Published: March 02, 2017
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
Journal: Human gene therapy
Published: February 18, 2016
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.
Journal: Current gene therapy
Published: August 25, 2014
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
Journal: Nature medicine
Published: July 12, 2013
HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.
Journal: Nature
Published: February 23, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026